Quarterly Reports :: Navidea Biopharmaceuticals, Inc. (NAVB)

Filing Type:

Year:

Date	Form	Description	Pages
08/08/18	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	53
05/09/18	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-10.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2	54
11/09/17	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	52
08/09/17	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	56
05/10/17	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-10.6 EX-31.1 EX-31.2 EX-32.1 EX-32.2	53
11/09/16	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	55
08/11/16	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-32.1	50
08/10/16	NT 10-Q	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB	4
05/16/16	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-32.1	44
05/10/16	NT 10-Q	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB	4